Antifibrotic	JJ	antifibrotic JJ PennPOS
properties	NNS	property NNS PennPOS
of	IN	of pp-f NUPOS
receptor	NN	receptor NN PennPOS
for	IN	for c-acp NUPOS
advanced	JJ	advanced JJ PennPOS
glycation	NN	glycation NN PennPOS
end	NN	end NN PennPOS
products	NNS	product NNS PennPOS
in	IN	in IN PennPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

Idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
is	VBZ	be vbz NUPOS
a	DT	a dt NUPOS
progressive	JJ	progressive JJ PennPOS
chronic	JJ	chronic JJ PennPOS
interstitial	JJ	interstitial JJ PennPOS
lung	NN	lung NN PennPOS
disease	NN	disease NN PennPOS
with	IN	with pp NUPOS
poor	JJ	poor JJ PennPOS
survival	NN	survival NN PennPOS
.	.	. . NUPOS

Previous	JJ	previous JJ PennPOS
reports	NNS	report NNS PennPOS
suggested	VBD	suggest VBD PennPOS
the	DT	the dt NUPOS
contributory	JJ	contributory JJ PennPOS
effect	NN	effect NN PennPOS
of	IN	of pp-f NUPOS
receptor	NN	receptor NN PennPOS
for	IN	for c-acp NUPOS
advanced	JJ	advanced JJ PennPOS
glycation	NN	glycation NN PennPOS
end	NN	end NN PennPOS
products	NNS	product NNS PennPOS
(	(	( ( NUPOS
RAGE	NN	rage NN PennPOS
)	)	) ) NUPOS
to	TO	to p-acp NUPOS
the	DT	the dt NUPOS
pathogenesis	NN	pathogenesis NN PennPOS
of	IN	of pp-f NUPOS
IPF	NN	IPF NN PennPOS
.	.	. . NUPOS

But	CC	but cc-acp NUPOS
the	DT	the dt NUPOS
findings	NNS	finding n2 NUPOS
are	VBP	be vbb NUPOS
controversial	JJ	controversial JJ PennPOS
.	.	. . NUPOS

The	DT	the dt NUPOS
present	JJ	present JJ PennPOS
in	FW	in fw-la NUPOS
vivo	FW	vivo fw-la NUPOS
study	NN	study NN PennPOS
with	IN	with pp NUPOS
RAGE	NN	rage NN PennPOS
null	JJ	null JJ PennPOS
mice	NNS	mouse n2 NUPOS
,	,	, , NUPOS
we	PRP	we pns12 NUPOS
further	RB	further av-jc NUPOS
confirmed	VBD	confirm VBD PennPOS
the	DT	the dt NUPOS
evidence	NN	evidence NN PennPOS
that	IN	that cst NUPOS
lack	NN	lack NN PennPOS
of	IN	of pp-f NUPOS
RAGE	NN	rage NN PennPOS
evolves	VBZ	evolve VBZ PennPOS
worse	JJR	bad JJR PennPOS
bleomycin-induced	JJ	bleomycin-induced JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
compared	VBN	compare VBN PennPOS
with	IN	with pp NUPOS
control	NN	control NN PennPOS
mice	NNS	mouse n2 NUPOS
.	.	. . NUPOS

Moreover	RB	moreover av NUPOS
,	,	, , NUPOS
RAGE	NN	rage NN PennPOS
null	JJ	null JJ PennPOS
mice	NNS	mouse n2 NUPOS
spontaneously	RB	spontaneous av-j NUPOS
developed	VBD	develop VBD PennPOS
similar	JJ	similar JJ PennPOS
pathogenesis	NN	pathogenesis NN PennPOS
of	IN	of pp-f NUPOS
lung	NN	lung NN PennPOS
fibrosis	NN	fibrosis NN PennPOS
via	IN	via IN PennPOS
immunohistochemical	JJ	immunohistochemical JJ PennPOS
staining	NN	staining NN PennPOS
.	.	. . NUPOS

In	IN	in IN PennPOS
addition	NN	addition NN PennPOS
,	,	, , NUPOS
we	PRP	we pns12 NUPOS
investigated	VBD	investigate VBD PennPOS
the	DT	the dt NUPOS
negative	JJ	negative JJ PennPOS
roles	NNS	role NNS PennPOS
of	IN	of pp-f NUPOS
RAGE	NN	rage NN PennPOS
on	IN	on IN PennPOS
epithelial-mesenchymal	JJ	epithelial-mesenchymal JJ PennPOS
transition	NN	transition NN PennPOS
(	(	( ( NUPOS
EMT	NN	emt NN PennPOS
)	)	) ) NUPOS
indicated	VBN	indicate VBN PennPOS
by	IN	by IN PennPOS
elevated	JJ	elevated JJ PennPOS
a-smooth-muscle-actin	NN	a-smooth-muscle-actin NN PennPOS
(	(	( ( NUPOS
a-SMA	NN	a-SMA NN PennPOS
)	)	) ) NUPOS
and	CC	and cc NUPOS
collagen-I	NN	collagen-I NN PennPOS
(	(	( ( NUPOS
Col-I	NN	Col-I NN PennPOS
)	)	) ) NUPOS
deposition	NN	deposition NN PennPOS
in	IN	in IN PennPOS
A549	NN	A549 NN PennPOS
cell	NN	cell NN PennPOS
treated	VBN	treat VBN PennPOS
with	IN	with pp NUPOS
transforming-growth-factor-b	NN	transforming-growth-factor-b NN PennPOS
(	(	( ( NUPOS
TGF-b	NN	TGF-b NN PennPOS
)	)	) ) NUPOS
,	,	, , NUPOS
all	DT	all d NUPOS
of	IN	of pp-f NUPOS
which	WDT	which r-crq NUPOS
were	VBD	be vbd NUPOS
blocked	VBN	block VBN PennPOS
by	IN	by IN PennPOS
sRAGE	NN	sRAGE NN PennPOS
,	,	, , NUPOS
a	DT	a dt NUPOS
decoy	NN	decoy NN PennPOS
receptor	NN	receptor NN PennPOS
.	.	. . NUPOS

Furthermore	RB	furthermore av NUPOS
,	,	, , NUPOS
interacting	VBG	interact VBG PennPOS
with	IN	with pp NUPOS
the	DT	the dt NUPOS
specific	JJ	specific JJ PennPOS
ligand	NN	ligand NN PennPOS
as	IN	as c-acp NUPOS
AGE	NN	age NN PennPOS
,	,	, , NUPOS
RAGE	NN	rage NN PennPOS
blocked	VBD	block VBD PennPOS
TGF-b-induced	JJ	tgf-b-induced JJ PennPOS
activation	NN	activation NN PennPOS
of	IN	of pp-f NUPOS
Smad2	NN	Smad2 NN PennPOS
,	,	, , NUPOS
ERK	NN	erk NN PennPOS
and	CC	and cc NUPOS
JNK	NN	jnk NN PennPOS
signals	NNS	signal NNS PennPOS
in	IN	in IN PennPOS
A549	NN	A549 NN PennPOS
cells	NNS	cell NNS PennPOS
,	,	, , NUPOS
which	WDT	which r-crq NUPOS
were	VBD	be vbd NUPOS
also	RB	also av NUPOS
challenged	VBN	challenge vvn NUPOS
by	IN	by IN PennPOS
sRAGE	NN	sRAGE NN PennPOS
administration	NN	administration NN PennPOS
.	.	. . NUPOS

This	DT	this d NUPOS
present	JJ	present JJ PennPOS
study	NN	study NN PennPOS
confirmed	VBD	confirm VBD PennPOS
an	DT	a dt NUPOS
important	JJ	important JJ PennPOS
role	NN	role NN PennPOS
of	IN	of pp-f NUPOS
RAGE	NN	rage NN PennPOS
in	FW	in fw-la NUPOS
vivo	FW	vivo fw-la NUPOS
and	CC	and cc NUPOS
vitro	FW	vitro FW PennPOS
models	NNS	model NNS PennPOS
of	IN	of pp-f NUPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
and	CC	and cc NUPOS
suggested	VBD	suggest VBD PennPOS
the	DT	the dt NUPOS
therapeutic	JJ	therapeutic JJ PennPOS
possibility	NN	possibility NN PennPOS
for	IN	for c-acp NUPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
via	IN	via IN PennPOS
RAGE	NN	rage NN PennPOS
regulation	NN	regulation NN PennPOS
.	.	. . NUPOS

